Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and Kidney Diseases

beta-lactams has been researched along with Kidney Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Bassetti, M; Bouglé, A; Jung, B; Lavigne, JP; Legrand, M; Leone, M; Neely, M; Paiva, JA; Payen, D; Rello, J; Roberts, JA; Roger, C; Sjövall, F1
Anjur, V; Bajaj, JS; Biggins, SW; Fallon, MB; Garcia-Tsao, G; Hu, C; Iyer, RK; Kamath, PS; Lai, JC; Maliakkal, B; O'Leary, J; Reddy, KR; Saboo, K; Subramanian, RM; Tandon, P; Thacker, LR; Thuluvath, P; Vargas, H; Wong, F1
Gatti, M; Pea, F1
Cosgrove, SE; Harris, AD; Hsu, AJ; Milstone, AM; Tamma, PD; Turnbull, AE1
Andréjak, M; Gras-Champel, V; Hary, L; Lemaire-Hurtel, AS; Masmoudi, K; Massy, Z1
Lagacé-Wiens, P; Rubinstein, E1
Baron, DN; Brumfitt, W; Hamilton-Miller, JM1
Tune, BM2
Heerema, MS; Musher, DM; Williams, TW1

Reviews

3 review(s) available for beta-lactams and Kidney Diseases

ArticleYear
Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors.
    Expert review of clinical pharmacology, 2021, Volume: 14, Issue:5

    Topics: Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Development; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Humans; Kidney Diseases

2021
Adverse reactions to β-lactam antimicrobials.
    Expert opinion on drug safety, 2012, Volume: 11, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Digestive System Diseases; Dose-Response Relationship, Drug; Drug Hypersensitivity; Hematologic Diseases; Humans; Kidney Diseases; Molecular Structure; Nervous System Diseases; Risk Assessment; Risk Factors; Structure-Activity Relationship

2012
Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention.
    Pediatric nephrology (Berlin, Germany), 1997, Volume: 11, Issue:6

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Humans; Kidney Diseases

1997

Other Studies

7 other study(ies) available for beta-lactams and Kidney Diseases

ArticleYear
Update in antibiotic therapy in intensive care unit: report from the 2019 Nîmes International Symposium.
    Anaesthesia, critical care & pain medicine, 2019, Volume: 38, Issue:6

    Topics: Administration, Inhalation; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Critical Care; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Drug Utilization; Drugs, Investigational; Europe; Extracorporeal Membrane Oxygenation; Forecasting; Humans; Intensive Care Units; Kidney Diseases; Microbial Sensitivity Tests; Microbiota; Nebulizers and Vaporizers; Peripheral Nervous System Diseases; Population Surveillance

2019
Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.
    The American journal of gastroenterology, 2021, 02-01, Volume: 116, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Ascites; beta-Lactams; Clinical Decision Rules; Cohort Studies; End Stage Liver Disease; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hydrothorax; Infections; Kidney Diseases; Lactulose; Liver Cirrhosis; Logistic Models; Machine Learning; Male; Middle Aged; Mortality; Paracentesis; Patient Readmission; Proton Pump Inhibitors; Reproducibility of Results; Rifaximin; ROC Curve; Severity of Illness Index; Support Vector Machine; Water-Electrolyte Imbalance

2021
Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.
    JAMA pediatrics, 2013, Volume: 167, Issue:10

    Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Comparative Effectiveness Research; Creatine; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infant; Kidney Diseases; Logistic Models; Male; Propensity Score; Retrospective Studies; Treatment Outcome

2013
[Recommended dosage adaptation based on renal function is not always sufficient to avoid betalactam antibiotics side effects].
    Nephrologie & therapeutique, 2009, Volume: 5, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Creatinine; Dose-Response Relationship, Drug; Epilepsy; Female; France; GABA Antagonists; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Practice Guidelines as Topic; Retrospective Studies

2009
Sodium content of injectable beta-lactam antibiotics.
    Lancet (London, England), 1984, May-19, Volume: 1, Issue:8386

    Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Injections, Intravenous; Kidney Diseases; Risk; Sodium; United Kingdom

1984
Clavulanic acid and penicillin treatment of Staphylococcus aureus renal infection in mice.
    Antimicrobial agents and chemotherapy, 1979, Volume: 16, Issue:6

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Kidney Diseases; Mice; Penicillin G; Staphylococcal Infections; Time Factors

1979
Mechanisms of nephrotoxicity of beta-lactam antibiotics.
    Contributions to nephrology, 1990, Volume: 83

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Kidney Diseases; Kidney Tubules; Mitochondria; Rabbits; Structure-Activity Relationship

1990